Events2Join

Refractory and Super|refractory Status Epilepticus


Refractory and Super-refractory Status Epilepticus - PMC

Refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE) are neurological emergencies with considerable mortality and morbidity.

Super-Refractory Status Epilepticus: Prognosis and Recent ...

This is a challenge due to their highly sedating properties and subsequent need to monitor for recurrence. The use of midazolam, phenobarbital, and propofol is ...

Super-refractory status epilepticus in adults

Super-refractory status epilepticus (SRSE) represents the culmination of refractory status epilepticus (RSE) and carries a significant risk ...

Refractory and super-refractory status epilepticus and evidence for ...

Few studies have investigated the use of ketamine in refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE).

Outcomes and Treatment Approaches for Super-Refractory Status ...

Super-refractory status epilepticus (SRSE) is defined as status epilepticus (SE) that continues or recurs 24 hours or more after the onset of ...

Refractory status epilepticus in adults - UpToDate

Outline · - Choice of infusion agent · - Concomitant antiseizure medications · - Goals of infusion therapy · - Efficacy and adverse effects · - ...

Factors associated with mortality in patients with super-refractory ...

Super-refractory status epilepticus (SRSE) is a critical condition in which seizures persist despite anesthetic use for 24 h or longer.

Ketamine to treat super-refractory status epilepticus - Neurology.org

Ketamine treatment was associated with a decrease in seizure burden in patients with SRSE. Our data support the notion that high-dose ketamine infusions are ...

Review Pediatric refractory and super-refractory status epilepticus

RSE and SRSE represent complex neurological emergencies associated with long-term neurological dysfunction and high mortality.

Refractory Status Epilepticus: Frequency, Risk Factors, and Impact ...

Refractory status epilepticus: frequency, risk factors, and impact on outcome. Stephan A. Mayer, MD; Jan Claassen, MD; Johnny Lokin, MD; et al Felicia ...

The treatment of super-refractory status epilepticus: a critical review ...

Barbiturate anaesthesia, using either thiopental or pentobarbital, is the traditional anaesthetic therapy for status epilepticus. The advantages ...

Refractory and Super-refractory Status Epilepticus

Results: Refractory status epilepticus is commonly defined as an acute convulsive seizure that fails to respond to two or more anti-seizure medications ...

Prolonged super-refractory status epilepticus with excellent seizure ...

Super-refractory status epilepticus (SRSE) is status epilepticus that continues or recurs despite intravenous anesthetic therapy. SRSE is ...

Management strategies for refractory status epilepticus

Refractory status epilepticus (RSE) is characterized by seizures that persist despite administration of first-line treatment with ben-.

Status Epilepticus, Refractory Status Epilepticus, and Super...

This article reviews the current definitions of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus

Super Refractory Status Epilepticus - Don't Forget the Bubbles

Super Refractory Status Epilepticus (SRSE) is a life-threatening neurological emergency with high morbidity and mortality.

Super-Refractory Status Epilepticus - Aging and disease

Super-refractory status epilepticus (SRSE) is a life-threatening neurological emergency with high morbidity and mortality.

Refractory and Super-Refractory Status Epilepticus

In refractory SE, general anesthetics should be used early in generalized convulsive and nonconvulsive SE in coma. ... In new-onset refractory SE/ ...

Refractory and super-refractory status epilepticus in children and ...

Highlights. •. The incidence of RSE/SRSE in children/adolescents is 3/100,000. •. Delays in initiating treatment occurred in various stages ...

Super-Refractory Status Epilepticus Linked With Unknown ...

Patients treated for more than 28 days had a higher chance of status epilepticus cessation, but also a high risk of moderate to severe ...